Phase 2B Double Blind, Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

Condition:   Gout Intervention:   Drug: SAP001 Sponsor:   Shanton Pharma Co., Ltd. Recruiting

Source: ClinicalTrials.gov - January 19, 2023 Category: Research Source Type: clinical trials